FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045976162> ?p ?o ?g. }

• W2045976162 endingPage "812" @default.
• W2045976162 startingPage "804" @default.
• W2045976162 abstract "Abstract Purpose This study examines the prevalence of depressive symptoms before prostate cancer treatment and explores associations among pre-treatment depressive symptoms and post-treatment disease-specific QOL, controlling for treatment modality, and demographic and clinical covariates. Materials and methods A case series of patients diagnosed with localized prostate cancer (T1-2N0M0) at a comprehensive cancer center was assessed. Of the 1,370 eligible patients, 869 (63.34%) completed questionnaires at diagnosis (baseline) and 6 months following treatment. Patients were treated with surgery (16.8%), brachytherapy (27.6%), or external beam radiation (EBRT; 55.6%). Depressive symptoms and disease-specific QOL were assessed with established measures (i.e., Center for Epidemiologic Studies Depression Scale (CES-D); sexual adjustment questionnaire (SAQ); and the American Urological Association symptom index). Results A fifth of the sample (19.7%) reported clinically elevated levels of depressive symptoms at baseline. The proportion of clinically elevated levels of baseline depressive symptoms was higher among surgery patients compared with patients treated with brachytherapy or external beam radiation. Depressive symptoms at baseline and treatment modality significantly predicted sexual and urinary dysfunction, related bother, activity limitation due to urinary dysfunction at 6 months, controlling for, age, PSA level, Gleason score, relevant baseline indicators of sexual and urinary dysfunction, related bother, and activity limitation ( P Conclusions Pretreatment depressive symptoms and treatment modality predict QOL after PrCa treatment. Health care providers should be sensitive to the display of depressive symptoms before PrCa treatment and consider preventative interventions, including preparing patients for the changes in disease-specific QOL and related bother following prostate cancer treatment." @default.
• W2045976162 created "2016-06-24" @default.
• W2045976162 creator A5034988446 @default.
• W2045976162 creator A5072404388 @default.
• W2045976162 creator A5074693624 @default.
• W2045976162 creator A5076417303 @default.
• W2045976162 creator A5087732297 @default.
• W2045976162 date "2012-11-01" @default.
• W2045976162 modified "2023-10-18" @default.
• W2045976162 title "Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific quality of life among patients with localized prostate cancer" @default.
• W2045976162 cites W1576323017 @default.
• W2045976162 cites W1876459006 @default.
• W2045976162 cites W1965966454 @default.
• W2045976162 cites W1972537539 @default.
• W2045976162 cites W1978693416 @default.
• W2045976162 cites W1993858687 @default.
• W2045976162 cites W2002955825 @default.
• W2045976162 cites W2020598365 @default.
• W2045976162 cites W2026755231 @default.
• W2045976162 cites W2034852146 @default.
• W2045976162 cites W2048765831 @default.
• W2045976162 cites W2049281237 @default.
• W2045976162 cites W2063107357 @default.
• W2045976162 cites W2078485795 @default.
• W2045976162 cites W2087887727 @default.
• W2045976162 cites W2088882993 @default.
• W2045976162 cites W2095000408 @default.
• W2045976162 cites W2098445827 @default.
• W2045976162 cites W2108183929 @default.
• W2045976162 cites W2112778345 @default.
• W2045976162 cites W2114089452 @default.
• W2045976162 cites W2123030672 @default.
• W2045976162 cites W2137449302 @default.
• W2045976162 cites W2142802556 @default.
• W2045976162 cites W2143584015 @default.
• W2045976162 cites W2156468631 @default.
• W2045976162 cites W2167597754 @default.
• W2045976162 cites W2170994552 @default.
• W2045976162 cites W2171069307 @default.
• W2045976162 cites W2993539218 @default.
• W2045976162 cites W4230368779 @default.
• W2045976162 cites W4231353044 @default.
• W2045976162 doi "https://doi.org/10.1016/j.urolonc.2011.02.002" @default.
• W2045976162 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4112499" @default.
• W2045976162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21795078" @default.
• W2045976162 hasPublicationYear "2012" @default.
• W2045976162 type Work @default.
• W2045976162 sameAs 2045976162 @default.
• W2045976162 citedByCount "27" @default.
• W2045976162 countsByYear W20459761622012 @default.
• W2045976162 countsByYear W20459761622013 @default.
• W2045976162 countsByYear W20459761622014 @default.
• W2045976162 countsByYear W20459761622015 @default.
• W2045976162 countsByYear W20459761622016 @default.
• W2045976162 countsByYear W20459761622017 @default.
• W2045976162 countsByYear W20459761622018 @default.
• W2045976162 countsByYear W20459761622019 @default.
• W2045976162 countsByYear W20459761622020 @default.
• W2045976162 countsByYear W20459761622021 @default.
• W2045976162 countsByYear W20459761622022 @default.
• W2045976162 crossrefType "journal-article" @default.
• W2045976162 hasAuthorship W2045976162A5034988446 @default.
• W2045976162 hasAuthorship W2045976162A5072404388 @default.
• W2045976162 hasAuthorship W2045976162A5074693624 @default.
• W2045976162 hasAuthorship W2045976162A5076417303 @default.
• W2045976162 hasAuthorship W2045976162A5087732297 @default.
• W2045976162 hasBestOaLocation W20459761622 @default.
• W2045976162 hasConcept C118552586 @default.
• W2045976162 hasConcept C121608353 @default.
• W2045976162 hasConcept C126322002 @default.
• W2045976162 hasConcept C143998085 @default.
• W2045976162 hasConcept C154945302 @default.
• W2045976162 hasConcept C159110408 @default.
• W2045976162 hasConcept C2776235491 @default.
• W2045976162 hasConcept C2779134260 @default.
• W2045976162 hasConcept C2779951463 @default.
• W2045976162 hasConcept C2780192828 @default.
• W2045976162 hasConcept C2780226545 @default.
• W2045976162 hasConcept C3019858935 @default.
• W2045976162 hasConcept C3020606620 @default.
• W2045976162 hasConcept C41008148 @default.
• W2045976162 hasConcept C558461103 @default.
• W2045976162 hasConcept C71924100 @default.
• W2045976162 hasConceptScore W2045976162C118552586 @default.
• W2045976162 hasConceptScore W2045976162C121608353 @default.
• W2045976162 hasConceptScore W2045976162C126322002 @default.
• W2045976162 hasConceptScore W2045976162C143998085 @default.
• W2045976162 hasConceptScore W2045976162C154945302 @default.
• W2045976162 hasConceptScore W2045976162C159110408 @default.
• W2045976162 hasConceptScore W2045976162C2776235491 @default.
• W2045976162 hasConceptScore W2045976162C2779134260 @default.
• W2045976162 hasConceptScore W2045976162C2779951463 @default.
• W2045976162 hasConceptScore W2045976162C2780192828 @default.
• W2045976162 hasConceptScore W2045976162C2780226545 @default.
• W2045976162 hasConceptScore W2045976162C3019858935 @default.
• W2045976162 hasConceptScore W2045976162C3020606620 @default.
• W2045976162 hasConceptScore W2045976162C41008148 @default.
• W2045976162 hasConceptScore W2045976162C558461103 @default.

• next